EDGAR Filing Documents for 0001171843-17-005147

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:

SEC Accession No. 0001171843-17-005147

Filing Date

2017-08-17

Accepted

2017-08-17 08:42:08

Documents

Period of Report

2017-08-16

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 6-K	f6k_072817.htm	6-K	10712
2	EXHIBIT 99.1	exh_991.htm	EX-99	21162
3	GRAPHIC	image_001.jpg	GRAPHIC	6904
	Complete submission text file	0001171843-17-005147.txt		42533

Mailing Address 545 PROMENADE DU CENTROPOLIS, SUITE 100 LAVAL A8 H7T 0A3

Business Address 545 PROMENADE DU CENTROPOLIS, SUITE 100 LAVAL A8 H7T 0A3 (450) 687-2262

Acasti Pharma Inc. (Filer) CIK: 0001444192 (see all company filings)